Mechanistic considerations in cancer risk assessment

Inhalation Toxicology

Volumn 11, Issue 6-7, 1999, Pages 549-554

  Williams, Gary M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0032861974     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/089583799196943     Document Type: Article

References (24)

1. Ames, B. N. 1973. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA 70:2281-2285.
2. Cohen, S. M., and Ellwein, L. B. 1990. Proliferative and genotoxic cellular effects in 2-acetylamino-fluorene bladder and liver carcinogenesis: Biological modeling of the EDO1 study. Toxicol. Appl. Pharmacol. 104:79-93.
3. Enzmann, H., Zerban, H., Kopp-Schneider, A., Löser, A., and Bannasch, P. 1995. Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis 16:1513-1418.
4. Gold, L. S., Manley, N., Slone, T., Garfinkel, G., Rohrback, L., and Ames, B. N. 1993. The fifth plot of the carcinogenic potency database: Results of animal bioassays published in the general literature through 1988, by the National Toxicology Program through 1989. Environ. Health Perspect. 100:65-135.
5. Goodman, J. I. 1994. A rational approach to risk assessment requires the use of biological information: An analysis of the National Toxicology Program (NTP) final report of the advisory review by the NTP Board of Scientific Counselors. Regul. Toxicol. Pharmacol. 19:51-59.
6. Hino, O., and Kitagawa, T. 1981. Existence of a practical threshold dose for the hepatocarcinogen 3′-methyl-4-(dimethylamino)azobenzene in rat liver. Gann 72:637-638.
7. International Agency for Research in Cancer. 1982. IARC Monogr. Eval. Carcinogen. Risk Chem. Man, Vol. 1-29, Suppl. 4, p. 13. Lyon, France: IARC.
8. International Expert Panel on Carcinogen Risk Assessment. 1996. The use of mechanistic data in the risk assessment of ten chemicals. Pharmacol. Ther. 71 (Special Issue):1-5.
9. Miller, E. C., and Miller, J. A. 1979. Milestones in chemical carcinogenesis. Sem. Oncol. 6:445-460.
10. Page, N. P., Singh, D. V., Farland, W., Goodman, J. I., Conolly, R. B., Anderson, M. E., Clewell, H. J., Frederick, C. B., Yamasaki, H., and Lucier, G. 1997. Implementation of EPA revised cancer assessment guidelines: Incorporation of mechanistic and pharmacokinetic data. Fundam. Appl. Toxicol. 37:16-36.
11. Poirier, M. C., and Beland, F. A. 1994. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents. Environ. Health Perspect. 102:161-165.
12. Presidential/Congressional Commission on Risk Assessment and Risk Management. 1997. Risk assessment and risk management in regulatory decision-making, Vol. 2. Washington, DC: US Government Printing Office.
13. Root, M., Lange, T., and Campbell, T. C. 1997. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver. Chem. Biol. Interact. 106:213-227.
14. Umemura, T., Tokumo, K., Gebhardt, R., Poirier, M., and Williams, G. M. 1993. Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett. 73:1-10.
15. Weisburger, J. H., and Williams, G. M. 1981. Carcinogen testing: Current problems and new approaches. Science 214:401-407.
16. Weisburger, J. H., and Williams, G. M. 1983. The distinct health risk analyses required for genotoxic carcinogens and promoting agents. Environ. Health Perspect. 50:233-245.
17. Whysner, J., and Williams, G. M. 1992. International cancer risk assessment: The impact of biologic mechanisms. Reg. Toxicol. Pharmacol. 15:41-50.
18. Whysner, J., Ross, P. M., and Williams, G. M. 1996. Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion. Pharm. Ther. 71:153-192.
19. Williams, G. M. 1987. Definition of a human cancer hazard. In Nongenotoxic mechanisms in carcinogenesis, pp. 367-380. Banbury Report 25. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
20. Williams, G. M., and Weisburger, J. H. 1986. Chemical carcinogens. In Casarett and Doull's toxicology: The basic sciences of poison, 3rd Ed., eds. C. D. Klaassen, M. O. Amdur, and J. Doull, pp. 99-173. New York: Macmillan.
21. Williams, G. M., and Whysner, J. 1996. Epigenetic carcinogens: Evaluation and risk assessment. Exp. Toxicol. Pathol. 48:189-195.
22. Williams, G. M., Gebhardt, R., Shirma, H., and Stenbäck, F. 1993. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis 14:2149-2156.
23. Williams, G. M., Iatropoulos, M. J., and Weisburger, J. H. 1996a. Chemical carcinogen mechanisms of action and implications for testing methodology. Exp. Toxicol. Pathol. 48:101-111.
24. Williams, G. M., Iatropoulos, M. J., Wang, C. X., Rivenson, A., Peterson, L. A., Schulz, C., and Gebhardt, R. 1996b. Diethylnitrosamine exposure-responses for DNA damage, centrilobular, cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit nonlinearities. Carcinogenesis 17:2253-2258.